These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27603338)

  • 1. High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation Cohort.
    Squillace N; Galli L; Bandera A; Castagna A; Madeddu G; Caramello P; Antinori A; Cattelan A; Maggiolo F; Cingolani A; Gori A; Monforte AD;
    Medicine (Baltimore); 2016 Sep; 95(36):e4434. PubMed ID: 27603338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
    Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
    AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of HIV infection and HAART on serum lipids in men.
    Riddler SA; Smit E; Cole SR; Li R; Chmiel JS; Dobs A; Palella F; Visscher B; Evans R; Kingsley LA
    JAMA; 2003 Jun; 289(22):2978-82. PubMed ID: 12799406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, timing, and determinants of bacterial pneumonia among HIV-infected patients: data from the ICONA Foundation Cohort.
    Mussini C; Galli L; Lepri AC; De Luca A; Antinori A; Libertone R; Angarano G; Bonfanti P; Castagna A; DʼArminio Monforte A;
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):339-45. PubMed ID: 23591636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
    Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
    HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapy.
    Padmapriyadarsini C; Ramesh K; Sekar L; Ramachandran G; Reddy D; Narendran G; Sekar S; Chandrasekar C; Anbarasu D; Wanke C; Swaminathan S
    Indian J Med Res; 2017 May; 145(5):641-650. PubMed ID: 28948955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis.
    Kawachi K; Kataoka H; Manabe S; Mochizuki T; Nitta K
    Heart Vessels; 2019 Sep; 34(9):1440-1455. PubMed ID: 30874893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy.
    Bandera A; Gori A; Sabbatini F; Madeddu G; Bonora S; Libertone R; Mastroianni C; Bonfanti P; d'Arminio Monforte A; Cozzi-Lepri A;
    PLoS One; 2015; 10(5):e0124252. PubMed ID: 25933346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein cholesterol in HIV-infected patients: evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition.
    Bernal E; Masiá M; Padilla S; Gutiérrez F
    AIDS Patient Care STDS; 2008 Jul; 22(7):569-75. PubMed ID: 18479224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study.
    Prosperi MC; Cozzi-Lepri A; Castagna A; Mussini C; Murri R; Giacometti A; Torti C; Costantini A; Narciso P; Ghinelli F; Antinori A; d'Arminio Monforte A;
    Clin Infect Dis; 2010 May; 50(9):1316-21. PubMed ID: 20297953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
    Mussini C; Lorenzini P; Puoti M; Lichtner M; Lapadula G; Di Giambenedetto S; Antinori A; Madeddu G; Cozzi-Lepri A; d'Arminio Monforte A; De Luca A;
    PLoS One; 2015; 10(12):e0140877. PubMed ID: 26640953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response association between the triglycerides: High-density lipoprotein cholesterol ratio and type 2 diabetes mellitus risk: The rural Chinese cohort study and meta-analysis.
    Cheng C; Liu Y; Sun X; Yin Z; Li H; Zhang M; Zhang D; Wang B; Ren Y; Zhao Y; Liu D; Zhou J; Liu X; Liu L; Chen X; Liu F; Zhou Q; Hu D
    J Diabetes; 2019 Mar; 11(3):183-192. PubMed ID: 30091266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
    McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
    Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of High-Density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson Disease.
    Park JH; Lee CW; Nam MJ; Kim H; Kwon DY; Yoo JW; Lee KN; Han K; Jung JH; Park YG; Kim DH
    Neurology; 2021 Mar; 96(10):e1391-e1401. PubMed ID: 33536275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus.
    Joo HJ; Cho SA; Hong SJ; Hur SH; Bae JH; Choi DJ; Ahn YK; Park JS; Choi RK; Choi D; Kim JH; Han KR; Park HS; Choi SY; Yoon JH; Kwon HC; Rha SW; Hwang KK; Jung KT; Oh SK; Lee JH; Shin ES; Kim KS; Kim HS; Lim DS
    Lipids Health Dis; 2016 Nov; 15(1):197. PubMed ID: 27863493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study.
    Yeh PS; Yang CM; Lin SH; Wang WM; Chen PS; Chao TH; Lin HJ; Lin KC; Chang CY; Cheng TJ; Li YH
    Atherosclerosis; 2013 Jun; 228(2):472-7. PubMed ID: 23618097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?
    Morton J; Ng MK; Chalmers J; Woodward M; Mancia G; Poulter NR; Marre M; Cooper ME; Zoungas S;
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1628-33. PubMed ID: 23780837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural population.
    Yokokawa H; Yasumura S; Tanno K; Ohsawa M; Onoda T; Itai K; Sakata K; Kawamura K; Tanaka F; Yoshida Y; Nakamura M; Terayama Y; Ogawa A; Okayama A
    J Atheroscler Thromb; 2011; 18(2):89-98. PubMed ID: 20972352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.